Xichun Hu

10PUBLICATIONS
51CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyPredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Mar 04, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Ting Li, Teng Zhou, Biyun Wang

|Dec 10, 2025
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Veronique Dieras, Giuseppe Curigliano, Miguel Martin

|Jul 31, 2025
Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Jian Zhang, Yanchun Meng, Biyun Wang

|Apr 17, 2025
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

Ting Zhao, Xiaowei Zhang, Xin Liu

|Sep 12, 2024
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.

Jian Zhang, Yiqun Du, Yanchun Meng

Pageof 2

Frequent Collaborators

3 joint publications

Jian Zhang

2 joint publications

Joohyuk Sohn

2 joint publications

Eriko Tokunaga

1 joint publications

Guang-Hai Dai